Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Placebo-controlled Trial to Investigate the Efficacy of Pediatric Prolonged-release Melatonin [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial is evaluating pediatric prolonged-release melatonin for sleep disturbances in children and adolesce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • melatonin (prolonged-release) (melatonin)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Post-traumatic Stress Disorder (PTSD), Current Significant Sleep Disturbances | Phase 3 | Status: NOT_YET_RECRUITING